NEOG

Neogen Corporation

Price

$12.15

return (12m)

116.58%

p/e

-325.20

p/bv

1.22

DIVIDEND YIELD

0.00%

NEOG price

Neogen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NEOG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

21.56%

3 months

37.13%

1 year

116.58%

2 years

-26.32%

5 years

-72.30%

10 years

-57.68%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals NEOG

Valuation

P/E

-325.20

Sector -4.38

Industry -4.38

P/BV

1.22

Sector 2.02

Industry 2.02

P/Revenue (PSR)

2.94

Sector -4.40

Industry -4.40

EV/EBITDA

86.16

Sector -263.09

Industry -263.09

EV/EBIT

1,761.55

Sector -702.90

Industry -702.90

P/EBITDA

14.90

Sector -4.39

Industry -4.39

P/EBIT

51.12

Sector -4.73

Industry -4.73

P/Total Assets

0.77

Sector 1.49

Industry 1.49

P/Net Current Assets

-3.95

Sector -11.70

Industry -11.70

P/Working Capital

5.74

Sector -3.19

Industry -3.19

EPS

-0.04

Sector -2.14

Industry -2.14

BVPS

9.60

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

46.93%

Sector 36.74%

Industry 36.74%

EBITDA Margin

16.33%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

0.80%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-2.49%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-0.91%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.07

Sector 0.03

Industry 0.03

Profitability

ROE

-0.38%

Sector -65.14%

Industry -65.14%

ROA

-0.24%

Sector -65.53%

Industry -65.53%

ROIC

0.38%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.82

Sector 2.90

Industry 2.90

Net Debt / EBITDA

16.53

Sector -6.07

Industry -6.07

Net Debt / EBIT

337.89

Sector -8.26

Industry -8.26

Net Debt / Equity

0.29

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.38

Sector -0.05

Industry -0.05

Equity/Assets

0.63

Sector 0.41

Industry 0.41

Liabilities/Assets

0.37

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

11.59%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals NEOG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NEOG Neogen Corporation	$12.15	119.31%	0.00%	-325.20	1.22	-0.38%	-0.91%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NEOG Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Neogen

Neogen Corporation

Average Investor10 user rating

4.0 (2 people)

United States

45 years

Founded: 1981

1989

Time since IPO - 37 years

1.841

Employees

Neogen Corporation (United States) is listed on the Nasdaq and has a market capitalization of $2.56 billion, with shareholders equity totaling $2.09 billion.

The company employs approximately 1.841 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Neogen Corporation reported $870.38 million in revenue, generating net income of $-7.88 million.

Key financial metrics include a P/E ratio of -325.20, a price-to-book (P/B) ratio of 1.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEOG.

Market cap

$2.56 billion

Net worth

$2.09 billion

$2,092,900,000.00

Assets

$3.35 billion

$3,346,000,000.00

Total Shares Outstanding

218.00 million

218,000,000

Average Daily Trading Volume

$2.06 million

$2,061,431.34

Sector

Health Care

Industry

Biotechnology

NEOG

NEOG revenue and profits

Financial Results NEOG

DRAG THE FRAME TO SEE MORE DATA

NEOG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Neogen (NEOG) today?

A cotação de Neogen (NEOG) hoje está em US$ 12.15, com uma variação de 116.58% em relação ao último ano. A cotação de Neogen (NEOG) iniciou o ano negociando na casa dos US$ 6.99 e hoje está em US$ 12.15. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Neogen (NEOG) e dados de ações do Ibovespa e mercados internacionais.

Quando Neogen (NEOG) paga dividendos?

Neogen (NEOG) não distribuiu dividendos no último ano.

Is Neogen (NEOG) a good investment?

Atualmente, Neogen (NEOG) está cotada a US$ 12.15, com um P/L de -325.20, representando um desvio de 21,961% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 116.58 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 116.58%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Neogen (NEOG) stock?

Investir em ações de Neogen (NEOG) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Neogen (NEOG) yield today?

A rentabilidade de Neogen (NEOG) foi de 21.56% no último mês, 116.58% no último ano e -72.30% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Neogen (NEOG) hoje, o investimento total seria de US$ 1,215.00, com base na cotação atual de US$ 12.15.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,631.45
Em 5 anos: US$ 336.56
Em 10 anos: US$ 514.19

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NEOG

Neogen Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NEOG

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NEOG WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Neogen

Neogen Corporation

United States

45 years

1989

1.841

PROFIT X PRICE NEOG

Financial Results NEOG

NEOG cash flow

Asset, Revenue and Profit Growth - NEOG

NEOG balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions